These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22374465)

  • 21. KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation.
    Kato K; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Uemura M; Asaoka T; Shimizu J; Doki Y; Eguchi H
    Cancer Sci; 2024 May; 115(5):1520-1535. PubMed ID: 38475666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma.
    Huang D; Ding Y; Li Y; Luo WM; Zhang ZF; Snider J; Vandenbeldt K; Qian CN; Teh BT
    Cancer Res; 2010 Feb; 70(3):1053-62. PubMed ID: 20103629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer.
    Morimoto H; Hida Y; Maishi N; Nishihara H; Hatanaka Y; Li C; Matsuno Y; Nakamura T; Hirano S; Hida K
    Thorac Cancer; 2021 May; 12(9):1347-1357. PubMed ID: 33709550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered angiogenesis and survival in human tumor-derived endothelial cells.
    Bussolati B; Deambrosis I; Russo S; Deregibus MC; Camussi G
    FASEB J; 2003 Jun; 17(9):1159-61. PubMed ID: 12709414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels.
    Schmid MC; Bisoffi M; Wetterwald A; Gautschi E; Thalmann GN; Mitola S; Bussolino F; Cecchini MG
    Int J Cancer; 2003 Feb; 103(5):577-86. PubMed ID: 12494464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-3 is a novel target to interfere with tumor vasculature.
    Dentelli P; Rosso A; Olgasi C; Camussi G; Brizzi MF
    Oncogene; 2011 Dec; 30(50):4930-40. PubMed ID: 21643009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Immortalized Human Tumor Endothelial Cells from Renal Cancer.
    Maishi N; Kikuchi H; Sato M; Nagao-Kitamoto H; Annan DA; Baba S; Hojo T; Yanagiya M; Ohba Y; Ishii G; Masutomi K; Shinohara N; Hida Y; Hida K
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment.
    Annan DA; Maishi N; Soga T; Dawood R; Li C; Kikuchi H; Hojo T; Morimoto M; Kitamura T; Alam MT; Minowa K; Shinohara N; Nam JM; Hida Y; Hida K
    Cell Commun Signal; 2019 Dec; 17(1):169. PubMed ID: 31847904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decorin and biglycan expression: its relation with endothelial heterogeneity.
    Calabrese GC; Gazzaniga S; Oberkersch R; Wainstok R
    Histol Histopathol; 2011 Apr; 26(4):481-90. PubMed ID: 21360441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid hormone affects the fibroblast growth factor-proteoglycan signaling axis to regulate osteosarcoma cell migration.
    Datsis GA; Berdiaki A; Nikitovic D; Mytilineou M; Katonis P; Karamanos NK; Tzanakakis GN
    FEBS J; 2011 Oct; 278(19):3782-92. PubMed ID: 21834878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
    Goka ET; Chaturvedi P; Lopez DTM; Lippman ME
    Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates.
    Goveia J; Rohlenova K; Taverna F; Treps L; Conradi LC; Pircher A; Geldhof V; de Rooij LPMH; Kalucka J; Sokol L; García-Caballero M; Zheng Y; Qian J; Teuwen LA; Khan S; Boeckx B; Wauters E; Decaluwé H; De Leyn P; Vansteenkiste J; Weynand B; Sagaert X; Verbeken E; Wolthuis A; Topal B; Everaerts W; Bohnenberger H; Emmert A; Panovska D; De Smet F; Staal FJT; Mclaughlin RJ; Impens F; Lagani V; Vinckier S; Mazzone M; Schoonjans L; Dewerchin M; Eelen G; Karakach TK; Yang H; Wang J; Bolund L; Lin L; Thienpont B; Li X; Lambrechts D; Luo Y; Carmeliet P
    Cancer Cell; 2020 Jan; 37(1):21-36.e13. PubMed ID: 31935371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor signals regulate transforming growth factor-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1.
    Akatsu Y; Takahashi N; Yoshimatsu Y; Kimuro S; Muramatsu T; Katsura A; Maishi N; Suzuki HI; Inazawa J; Hida K; Miyazono K; Watabe T
    Mol Oncol; 2019 Aug; 13(8):1706-1724. PubMed ID: 31094056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
    Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Biglycan in First Trimester Chorionic Villous Sampling Placental Samples and Altered Function in Telomerase-Immortalized Microvascular Endothelial Cells.
    Chui A; Gunatillake T; Brennecke SP; Ignjatovic V; Monagle PT; Whitelock JM; van Zanten DE; Eijsink J; Wang Y; Deane J; Borg AJ; Stevenson J; Erwich JJ; Said JM; Murthi P
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1168-1179. PubMed ID: 28408374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
    Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
    Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition.
    Xiao L; Kim DJ; Davis CL; McCann JV; Dunleavey JM; Vanderlinden AK; Xu N; Pattenden SG; Frye SV; Xu X; Onaitis M; Monaghan-Benson E; Burridge K; Dudley AC
    Cancer Res; 2015 Apr; 75(7):1244-54. PubMed ID: 25634211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
    Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
    Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells.
    Hu C; Shen SQ; Cui ZH; Chen ZB; Li W
    World J Gastroenterol; 2015 May; 21(19):5884-92. PubMed ID: 26019452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.
    Fan B; Jin Y; Zhang H; Zhao R; Sun M; Sun M; Yuan X; Wang W; Wang X; Chen Z; Liu W; Yu N; Wang Q; Liu T; Li X
    Int J Oncol; 2020 Jan; 56(1):178-192. PubMed ID: 31789394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.